From: Open-label study of treatment with alendronate sodium plus vitamin D in men and women with osteoporosis in Thailand
Percent Reduction of β-CTx
Group I (N = 28)
Group II (N = 64)
Group III (N = 94)
Total (N = 186)
≥ 30%, n (%)
12 (42.9)
44 (68.7)
91 (96.8)
147 (79.0)
≥ 50%, n (%)
7 (25.0)
37 (57.8)
89 (94.7)
133 (71.5)